Romunija -
romunščina -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
nimotop 10 mg/50 ml
bayer ag - germania - nimodipinum - sol. perf. - 10mg/50ml - bloc. selective canale calciu cu ef. preponderent vascular derivati dihidropiridinici
Evropska unija -
romunščina -
EMA (European Medicines Agency)
tachosil
corza medical gmbh - fibrinogenul uman, trombina umană - hemostază, chirurgicală - hemostatice - tachosil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular surgery where standard techniques are insufficient. tachosil is indicated in adults for supportive sealing of the dura mater to prevent postoperative cerebrospinal leakage following neurological surgery (see section 5.
Romunija -
romunščina -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
memovist 1 mmol/ml
bayer ag - germania - gadobutrolum - sol. inj. - 1mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice
Evropska unija -
romunščina -
EMA (European Medicines Agency)
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologice - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Romunija -
romunščina -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
dotagraf 0,5 mmol/ml
sanochemia pharmazeutika gmbh - austria - acid gadotericum - sol. inj. in flac. unidoza - 0,5mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice
Romunija -
romunščina -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
nimotop 30 mg
bayer ag - germania - nimodipinum - compr. film. - 30mg - bloc. selective canale calciu cu ef. preponderent vascular derivati dihidropiridinici
Evropska unija -
romunščina -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Evropska unija -
romunščina -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
Moldavija -
romunščina -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
avelox solutie perfuzabila 400 mg/250 ml
bayer ag - moxifloxacinum - solutie perfuzabila - 400 mg/250 ml
Evropska unija -
romunščina -
EMA (European Medicines Agency)
iblias
bayer ag - octocog alfa - hemofilia a - hemostatice - tratamentul și profilaxia hemoragiilor la pacienții cu hemofilie a (deficit congenital de factor viii). iblias poate fi utilizat pentru toate grupele de vârstă.